01 1Lonza Biologics Inc
01 1TOSITUMOMAB [MURINE MONOCLONAL ANTIBODY (B1) AGAINST B LYMPHOCYTES (CD20)]
01 1U.S.A
01 1Inactive
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18661
Submission : 1999-06-30
Status : Inactive
Type : II
20
Lonza Biologics Plc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TOSITUMOMAB [MURINE MONOCLONAL ANTIBODY (B1) AGAINST B LYMPHOCYTES (CD20)], with a corresponding US DMF Number 18661.
Remarkably, this DMF maintains an Inactive status since its submission on June 30, 1999, highlighting commitment to regulatory compliance.
